amlodipine has been researched along with Pulmonary Hypertension in 13 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results show that oral amlodipine can produce acute pulmonary vasodilatation in patients with pulmonary hypertension." | 9.08 | Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension. ( Channer, KS; Morice, AH; O'Toole, L; Woodmansey, PA, 1996) |
| "The aim of the study was to investigate the pulmonary vasodilator effect of the dihydropyridine calcium channel blocker amlodipine in patients with clinically stable chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH)." | 7.71 | The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease. ( Franz, IW; Schaupp, S; Tönnesmann, U; Van Der Meyden, J, 2002) |
| "This study was designed to evaluate the effects of amlodipine, a new calcium channel blocker, on the development of right ventricular hypertrophy and thickening of the media of the pulmonary arteries in a rat model of pulmonary hypertension." | 7.69 | Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension. ( Imai, S; Kanda, T; Kobayashi, I; Nagai, R; Suzuki, T; Takahashi, T, 1996) |
| "These results show that oral amlodipine can produce acute pulmonary vasodilatation in patients with pulmonary hypertension." | 5.08 | Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension. ( Channer, KS; Morice, AH; O'Toole, L; Woodmansey, PA, 1996) |
| "The aim of the study was to investigate the pulmonary vasodilator effect of the dihydropyridine calcium channel blocker amlodipine in patients with clinically stable chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH)." | 3.71 | The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease. ( Franz, IW; Schaupp, S; Tönnesmann, U; Van Der Meyden, J, 2002) |
| "This study investigated whether pulmonary vascular remodelling in hypoxic pulmonary hypertensive rats (10% oxygen; 4 weeks) could be prevented by treatment, during hypoxia, with amlodipine (10 mg/kg/day, p." | 3.71 | Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril. ( Jeffery, TK; Wanstall, JC, 2001) |
| "This study was designed to evaluate the effects of amlodipine, a new calcium channel blocker, on the development of right ventricular hypertrophy and thickening of the media of the pulmonary arteries in a rat model of pulmonary hypertension." | 3.69 | Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension. ( Imai, S; Kanda, T; Kobayashi, I; Nagai, R; Suzuki, T; Takahashi, T, 1996) |
| " We have compared the pulmonary vasodilator effects, dose-response characteristics, and tolerability of two calcium channel blockers, amlodipine and extended-release (ER) felodipine, in 10 patients (seven men, age 68+/-4." | 2.68 | A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. ( Alpers, JA; Bune, AJ; Frith, PA; McEvoy, RD; Sajkov, D; Wang, T, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikhalkova, D | 1 |
| Fenstad, ER | 1 |
| Miller, WL | 1 |
| Dmuchowska, DA | 1 |
| Zalewska, R | 1 |
| Jasiewicz, M | 1 |
| Krasnicki, P | 1 |
| Mikita, A | 1 |
| Sobkowicz, B | 1 |
| Mariak, Z | 1 |
| Sarraf, D | 1 |
| Johri, S | 1 |
| Dunnington, GH | 1 |
| Vnencak-Jones, CL | 1 |
| Franz, IW | 1 |
| Van Der Meyden, J | 1 |
| Schaupp, S | 1 |
| Tönnesmann, U | 1 |
| Schröder, A | 1 |
| Schumacher, T | 1 |
| Tromm, A | 1 |
| Higashide, T | 1 |
| Okai, T | 1 |
| Yoshida, S | 1 |
| Tonoike, N | 1 |
| Kakihara, M | 1 |
| Mizumura, T | 1 |
| Oshima, A | 1 |
| Sugimura, Y | 1 |
| Tamamura, T | 1 |
| Ogata, I | 1 |
| Mawatari, E | 1 |
| Hongo, M | 1 |
| Sakai, A | 1 |
| Terasawa, F | 1 |
| Takahashi, M | 1 |
| Yazaki, Y | 1 |
| Kinoshita, O | 1 |
| Ikeda, U | 1 |
| Woodmansey, PA | 2 |
| Zhang, F | 1 |
| Channer, KS | 2 |
| Morice, AH | 2 |
| O'Toole, L | 1 |
| Takahashi, T | 1 |
| Kanda, T | 1 |
| Imai, S | 1 |
| Suzuki, T | 1 |
| Kobayashi, I | 1 |
| Nagai, R | 1 |
| Sajkov, D | 1 |
| Wang, T | 1 |
| Frith, PA | 1 |
| Bune, AJ | 1 |
| Alpers, JA | 1 |
| McEvoy, RD | 1 |
| Jeffery, TK | 1 |
| Wanstall, JC | 1 |
2 trials available for amlodipine and Pulmonary Hypertension
| Article | Year |
|---|---|
Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac | 1996 |
A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Dose-Re | 1997 |
11 other studies available for amlodipine and Pulmonary Hypertension
| Article | Year |
|---|---|
34-year-old man with exertional syncope, dyspnea, and chest pain.
Topics: Adult; Amlodipine; Antihypertensive Agents; Chest Pain; Dyspnea; Electrocardiography; Humans; Hypert | 2013 |
Diagnostic and Therapeutic Challenges.
Topics: Amlodipine; Antihypertensive Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Hum | 2015 |
[RIGHT VENTRICULAR DIASTOLIC FUNCTION AND PERIPHERAL HEMODYNAMICS IN PATIENTS WITH CHRONIC COR PULMONALE RECEIVING VARIOUS THERAPY REGIMENS].
Topics: Amlodipine; Antihypertensive Agents; Echocardiography, Doppler, Color; Female; Hemodynamics; Humans; | 2010 |
A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.
Topics: Aged, 80 and over; Amlodipine; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Digoxin; Dys | 2010 |
The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
Topics: Amlodipine; Calcium Channel Blockers; Confidence Intervals; Data Interpretation, Statistical; Exerci | 2002 |
[Kyphoscoliosis as a cause of pulmonary hypertension].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Block | 2003 |
[Basedow disease with recurrent syncopal attack and severe pulmonary hypertension].
Topics: Aged; Amlodipine; Atrial Fibrillation; Digoxin; Female; Graves Disease; Humans; Hypertension, Pulmon | 2007 |
Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Topics: Amlodipine; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Blotting, We | 2007 |
Vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats.
Topics: Amlodipine; Animals; Aorta; Chronic Disease; Dose-Response Relationship, Drug; Hypertension, Pulmona | 1993 |
Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Hypertension, Pulmonary; Hypertrophy, Right Ventricul | 1996 |
Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Heart Ventricles; Hypertension, Pulmon | 2001 |